Suppression of ovarian cancer growth and metastasis with HO-3867, a STAT3 inhibitor, in human tissue culture and in an orthotopic mouse model

ElNaggar, Adam

502
Suppression of ovarian cancer growth and metastasis with HO-3867, a STAT3 inhibitor, in human tissue culture and in an orthotopic mouse model

Sunday, March 29, 2015: 7:00 AM

Salon C-D (Hilton Chicago)

S. Naidu¹, U. Saini¹, A. C. ElNaggar², K. Rath², B. K. Hemant¹, P. Lata¹, R. Wanner¹, M. Sudhakar¹, A. Suarez¹, J. Hays², P. J. Goodfellow¹, D. E. Cohn² and S. Karuppaiyah¹
¹The Ohio State University Medical Center, Columbus, OH, ²The Ohio State University, James Cancer Hospital, Columbus, OH

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

502
Suppression of ovarian cancer growth and metastasis with HO-3867, a STAT3 inhibitor, in human tissue culture and in an orthotopic mouse model

502 Suppression of ovarian cancer growth and metastasis with HO-3867, a STAT3 inhibitor, in human tissue culture and in an orthotopic mouse model

502
Suppression of ovarian cancer growth and metastasis with HO-3867, a STAT3 inhibitor, in human tissue culture and in an orthotopic mouse model